Leo Pharma recalls

Leo Pharma has 3 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 4 Mar 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is particulate matter.

Total recalls3since 2017

Last 12 months1reported

Class I00% of total

Ongoing1latest 4 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 1 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why leo pharma is recalled

Product types

Creams, Ointments & Gels267%
Injectable & IV Drugs133%

Brands

By year

2026133%
2017267%

Ongoing leo pharma recalls

1 active

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS II	Adbry, (tralokinumab-ldrm) injection, 300 mg recalled by Leo PharmaAdbry	Leo Pharma	Particulate Matter	Nationwide

All leo pharma recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS II	Adbry, (tralokinumab-ldrm) injection, 300 mg recalled by Leo PharmaAdbry	Leo Pharma	Particulate Matter	Nationwide
15 Mar 2017Drug	CLASS II	Calcipotriene Cream recalled by Leo PharmaCalcipotriene	Leo Pharma	Labeling Errors	Nationwide
22 Feb 2017Drug	CLASS III	Taclonex (calcipotriene and betamethasone dipropionate) recalledTaclonex	Leo Pharma	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.